Back to Search Start Over

Pulmonary carcinoid tumours: A multi-centre analysis of survival and predictors of outcome following sublobar, lobar, and extended pulmonary resections

Authors :
Daniel Florisson
Siven Seevanayagam
Nima Yaftian
Naveed Z. Alam
Jean Lee
Stacy Telianidis
Sameer Thakur
Stephen Barnett
Phillip Antippa
Simon Knight
Gavin M. Wright
Source :
Asian Cardiovascular and Thoracic Annals. 29:532-540
Publication Year :
2021
Publisher :
SAGE Publications, 2021.

Abstract

Background Pulmonary carcinoids are rare neoplasms, accounting for approximately 1%–2% of all lung malignancies. A retrospective analysis was undertaken of all patients who underwent surgical resection of pulmonary carcinoid tumours across multiple institutions in Melbourne, Australia. Methods From May 2000 through April 2020, 241 patients who underwent surgical resection of pulmonary carcinoid tumours were retrospectively reviewed. Patient demographics, pathologic data, and long-term outcomes were recorded. Results Median age was 57.7 years and the majority of patients were female (58.9% vs. 41.1%). Typical carcinoid was present in 77.1%. Histological subtype was associated with several factors. Atypical carcinoid was more likely to have larger tumour size and nodal involvement. Overall survival for typical carcinoid at 5, 10, and 15 years was 98%, 95%, and 84%, and for atypical carcinoid was 88%, 82%, and 62%, respectively. Histological subtype and age were found to be independent predictors of overall survival, with worse outcomes for atypical and those above 60 years of age. Disease-free survival was related to sublobar resection (p Conclusion Excellent long-term outcomes can be achieved following surgical resection of pulmonary carcinoids. Atypical histology and lymph node involvement are significant prognostic factors, and sublobar resection should not be considered in patients with either of the above features. Typical carcinoid tumour without nodal involvement may be appropriate for sublobar resection. Typical and atypical carcinoid tumours should be considered distinct disease entities, and as such treated accordingly.

Details

ISSN :
18165370 and 02184923
Volume :
29
Database :
OpenAIRE
Journal :
Asian Cardiovascular and Thoracic Annals
Accession number :
edsair.doi.dedup.....b977e1566c0cc2e14f0fa55178a21d69
Full Text :
https://doi.org/10.1177/02184923211010090